文章核心观点 公司完成首次公开募股，拟用所得款项进行业务合并，重点在亚洲寻找目标企业 [1][2][5] 公司IPO情况 - 公司完成600万单位首次公开募股，发行价为每单位10美元，单位由一股普通股和半份可赎回认股权证组成 [1] - 单位于2025年7月2日在纳斯达克全球市场开始交易，代码为“ORIQU” [1] - 每份完整认股权证持有人有权以每股11.50美元价格购买一股普通股，自公司首次业务合并完成30天后可行使，有效期为业务合并完成后五年 [1] - 证券开始单独交易后，普通股和认股权证预计分别以“ORIQ”和“ORIQW”代码在纳斯达克交易，分离时不发行零碎认股权证，仅完整认股权证可交易 [1] - 公司授予承销商45天选择权，可按首次公开募股价格购买最多90万额外单位以应对超额配售 [1] 资金用途 - 公司拟用此次发行所得款项及同时进行的单位私募所得款项，与一家或多家企业进行业务合并 [2] 发行相关信息 - ThinkEquity担任此次发行唯一账簿管理人 [2] - 与单位相关的S - 1表格注册声明于2025年7月1日向美国证券交易委员会提交并生效，此次发行仅通过招股说明书进行 [3] - 最终招股说明书副本可从ThinkEquity获取，也可在美国证券交易委员会网站查询 [3] 公司概况 - 公司是空白支票公司（特殊目的收购公司），旨在与一家或多家企业进行合并、股份交换、资产收购等业务合并 [5] - 公司不将目标公司搜索范围局限于特定业务领域，但打算重点在亚洲寻找目标企业，不会与中国实体或通过可变利益实体结构合并中国业务的企业进行首次业务合并 [5] 联系方式 - 首席执行官为Edward Chang，联系电话+65 7825 - 5768，邮箱eychang@originequity.partners [7]

文章核心观点 EQV Ventures Acquisition Corp. II完成首次公开募股，总收益达4.6亿美元，单位已在纽交所交易 [1][2] 分组1：首次公开募股情况 - 公司完成4200万单位首次公开募股，从3500万单位扩量，每单位价格10美元，承销商部分行使超额配售权额外出售400万单位，总收益4.6亿美元 [1] 分组2：交易情况 - 公司单位于2025年7月2日在纽交所以“EVACU”代码开始交易 [2] - 单位分离后，A类普通股和认股权证预计分别以“EVAC”和“EVACW”代码在纽交所上市 [3] 分组3：单位构成 - 每个单位包含一股A类普通股和三分之一可赎回认股权证，每份完整认股权证持有人有权以每股11.50美元价格购买一股A类普通股，有一定调整条件，分离时不发行零碎认股权证，仅完整认股权证可交易 [3] 分组4：发行相关方 - BTIG, LLC担任此次发行的唯一簿记管理人 [4] 分组5：文件获取 - 可从BTIG, LLC获取最终招股说明书副本，地址为纽约东55街65号，邮编10022，收件人：辛迪加部门，也可发邮件至ProspectusDelivery@btig.com [4] - 与这些证券相关的注册声明已提交美国证券交易委员会，于2025年7月1日生效 [4] 分组6：投资者联系方式 - 投资者联系邮箱为IR@eqvventures.com [8]

Selangor, Malaysia, July 03, 2025 (GLOBE NEWSWIRE) -- Empro Group Inc. (the “Company” or “EMPG”), a rising beauty and personal care brand headquartered in Malaysia, today announced the closing of its initial public offering (the "Offering") of 1,375,000 ordinary shares (the "Ordinary Shares") at an initial public offering price of $4.00 per share for total gross proceeds of approximately $5,500,000, before deducting underwriting discounts and other offering expenses. The Offering closed on July 3, 2025, and ...

PLYMOUTH MEETING, Pa., July 3, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the pricing of an underwritten public offering of 14,285,715 shares of its common stock and accompanying Series A warrants to purchase up to 14,285,715 shares of its common stock (or pre-funded warrants in lieu thereof) at an e ...

HAMILTON, Bermuda, July 2, 2025 /PRNewswire/ -- Borr Drilling Limited (the "Company") (NYSE: BORR) announces today its plans for a public offering seeking to raise $100 million in gross proceeds though an offering of approximately 50 million shares.The Company plans to use the proceeds from the offering for general corporate purposes, which may include debt service, capital expenditures and funding of working capital.DNB Carnegie, Clarksons Securities, Citigroup and Goldman Sachs & Co. LLC are joint bookrun ...

BEIJING, July 02, 2025 (GLOBE NEWSWIRE) -- Julong Holding Limited (“Julong” or the “Company”) (Nasdaq: JLHL), a growth-oriented provider of intelligent integrated solutions, today announced that, in connection with its previously completed initial public offering (the "Offering") of its Class A ordinary shares, the underwriter has exercised its over-allotment option in full to purchase an additional 187,500 Class A ordinary shares at the public offering price from the Company, bringing additional gross proc ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Indigo Acquisition Corp. (the “Company”) announced today that it closed its initial public offering of 10,000,000 units at $10.00 per unit. The offering resulted in gross proceeds to the Company of $100,000,000. The Company’s units are listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “INACU.” Each unit consists of one ordinary share and one right entitling its holder to receive one tenth of one ordinary share upon the Company’s compl ...

PHILADELPHIA, PA, July 02, 2025 (GLOBE NEWSWIRE) -- Cohen Circle Acquisition Corp. II (NASDAQ:CCIIU) (the “Company”) today announced the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000. The Company’s units began trading on the Nasdaq Global Market (“Nasdaq”) on July 1, 2025 under the tic ...

文章核心观点 NMP Acquisition Corp.宣布完成1000万单位的首次公开募股，介绍了单位构成、交易安排等情况，还提及承销商、注册声明等相关信息 [1] 分组1：首次公开募股情况 - 公司完成1000万单位的首次公开募股，发行价为每单位10美元，每单位含一股A类普通股和一份认股权 [1] - 认股权持有人在公司首次业务合并完成时有权获得五分之一股A类普通股 [1] - 单位于2025年7月1日在纳斯达克全球市场以“NMPAU”代码开始交易，证券分开交易后，A类普通股和认股权预计分别以“NMP”和“NMPAR”代码交易 [1] 分组2：承销相关 - Maxim Group LLC担任此次发行的唯一簿记管理人 [2] - 公司授予承销商45天选择权，可按首次公开募股价格减去承销折扣购买最多150万额外单位以覆盖超额配售 [2] 分组3：注册声明与招股书 - 与此次发行相关的S - 1表格注册声明于2025年6月30日获美国证券交易委员会宣布生效 [3] - 此次发行仅通过招股书进行，可从Maxim Group LLC获取招股书副本 [3] 分组4：公司性质 - NMP Acquisition Corp.是一家空白支票公司，即特殊目的收购公司（SPAC），旨在与一家或多家企业进行业务合并 [5] 分组5：联系信息 - 公司CEO为Melanie Figueroa，投资者关系联系邮箱为ir@nmpspac.com [7]

Hong Kong, July 02, 2025 (GLOBE NEWSWIRE) -- GRANDE GROUP LIMITED (“GRAN” or the “Company”), a Hong Kong-based financial services provider which principally engages in the provision of corporate finance advisory services and IPO sponsor services through its Hong Kong subsidiary, Grande Capital Limited, today announced the closing of its initial public offering (the “Offering”) of 1,875,000 Class A ordinary shares (the “Class A Ordinary Shares”) at the price of $5.00 per share (the “Offering Price”). The Cl ...